Sign inJoin waitlistJoin the waitlist

Neil Horowitz

Physician · UMass Memorial Health

Credentials: · · · ·

History

UMass Memorial Health
2026–Present

Complex Family Planning
Washington University/B-JH/SLCH Consortium
2006–2008
Gynecologic Oncology
Barnes-Jewish Hospital
2003–2006
Gynecologic Oncology
University of Washington School of Medicine
2000–2003
Obstetrics and Gynecology
University of Washington Medical Center - Montlake
1996–1997
Duke University School of Medicine
1992–1996

Research

Prediction of DNA Repair Inhibitor Response in Short-Term Patient-Derived Ovarian Cancer Organoids
Cancer Discovery · 2018 · 375 citations
Drug-induced death signaling strategy rapidly predicts cancer response to chemotherapy
Cell · 2015 · 301 citations
Cediranib, an oral inhibitor of vascular endothelial growth factor receptor kinases, is an active drug in recurrent epithelial ovarian, fallopian tube, and peritoneal cancer
Journal of Clinical Oncology · 2009 · 238 citations

Ross Berkowitz
123 papers
Kevin Elias
69 papers
Ursula Matulonis
42 papers
Marcela del Carmen
31 papers · 13 as a resident
MM
Michael Muto
27 papers
DG
Donald Goldstein
26 papers
Susana Campos
26 papers
Whitfield Growdon
26 papers · 5 as a fellow
Carolyn Krasner
23 papers
Joyce Liu
23 papers
Colleen Feltmate
22 papers
MW
Michael Worley
22 papers · 9 as a resident

Clinical trials

Detection of Tumor Associated Cell-free DNA in Peritoneal Fluid Obtained by Culdocentesis
Principal investigator · Terminated
Dana-Farber Cancer Institute
2015–2019
Radiation Therapy, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Locally Advanced Squamous Cell Cancer of the Vulva
Principal investigator · Unknown · Phase 2
Gynecologic Oncology Group
2012–2022
Erlotinib in Women With Squamous Cell Carcinoma of the Vulvar
Principal investigator · Completed · Phase 2
Dana-Farber Cancer Institute
2006–2012
Oxaliplatin, Gemcitabine and Bevacizumab in Women With Recurrent Mullerian Carcinoma
Principal investigator · Terminated · Phase 2
Dana-Farber Cancer Institute
2006–2011